PRESS RELEASE published on 07/02/2025 at 22:00, 5 months 19 days ago Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
BRIEF published on 06/10/2025 at 22:05, 6 months 10 days ago Renée Aguiar-Lucander Joins Inventiva's Board of Directors Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF published on 06/10/2025 at 22:05, 6 months 10 days ago Renée Aguiar-Lucander rejoint le conseil d'administration d'Inventiva Conseil D'administration Biopharmaceutique Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE published on 06/10/2025 at 22:00, 6 months 11 days ago Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF published on 05/27/2025 at 22:05, 6 months 24 days ago Inventiva aux Conférences Jefferies et UBS sur la Santé Biopharmaceutique Inventiva Conférence Jefferies MASH Conférence UBS
BRIEF published on 05/27/2025 at 22:05, 6 months 24 days ago Inventiva at the Jefferies and UBS Healthcare Conferences Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE published on 05/27/2025 at 22:00, 6 months 25 days ago Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
PRESS RELEASE published on 05/27/2025 at 22:00, 6 months 25 days ago Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference » Inventiva participera à deux conférences investisseurs en juin 2025 : Jefferies Global Healthcare Conference et UBS Spring Biotech Conference. Présentation stratégique de la société et du médicament Lanifibranor Conférences Investisseurs Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF published on 05/23/2025 at 08:35, 6 months 29 days ago Inventiva publie ses résultats financiers du premier trimestre 2025 : la trésorerie diminue Résultats Financiers Essai Clinique Situation De Trésorerie Inventiva Lanifibranor
BRIEF published on 05/23/2025 at 08:35, 6 months 29 days ago Inventiva Reports First Quarter 2025 Financials: Cash Position Declines Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
Published on 12/20/2025 at 00:30, 1 day 21 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 18:30, 2 days 3 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 7 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 8 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/21/2025 at 08:55, 13 hours 7 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 5 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 11 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 2 days ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 days ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 21:57, 2 days ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 13 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 13 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION